EDGEWELL PERSONAL CARE Co (EPC) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — EPC

Balance Sheet

(in billions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	0.40	0.30	0.22	0.20	0.17	0.18	0.20	0.20	0.21	0.21	0.16	0.18	0.19	0.24	0.44	0.28	0.28
Accounts Receivable	0.12	0.19	0.15	0.15	0.18	0.12	0.16	0.13	0.11	0.12	0.16	0.16	0.18	0.15	0.15	0.20	0.17
Inventory	0.43	0.45	0.46	0.49	0.51	0.50	0.46	0.50	0.52	0.50	0.54	0.41	0.43	0.41	0.36	0.35	0.34
Total Current Assets	1.11	1.11	1.06	1.00	1.01	0.95	0.96	0.99	1.01	0.99	1.01	0.93	0.97	0.97	1.10	0.99	0.93
Property, Plant & Equipment	0.29	0.29	0.29	0.36	0.34	0.34	0.33	0.33	0.33	0.34	0.34	0.35	0.36	0.36	0.36	0.36	0.37
Goodwill	1.13	1.13	1.14	1.34	1.33	1.33	1.33	1.33	1.34	1.34	1.33	1.33	1.34	1.34	1.17	1.16	1.17
Intangible Assets	0.24	0.24	0.25	0.33	0.33	0.34	0.36	0.37	0.37	0.39	0.40	0.42	0.43	0.44	0.31	0.32	0.32
Total Non-current Assets*	2.42	2.42	2.71	2.79	2.76	2.76	2.75	2.76	2.78	2.78	2.79	2.79	2.82	2.84	2.55	2.55	2.56
Total Assets	3.54	3.53	3.77	3.79	3.77	3.70	3.71	3.76	3.79	3.77	3.80	3.72	3.79	3.81	3.65	3.54	3.50
Accounts Payable	0.23	0.23	0.21	0.22	0.22	0.20	0.21	0.22	0.20	0.24	0.25	0.24	0.22	0.22	0.22	0.19	0.18
Total Current Liabilities	0.60	0.61	0.50	0.57	0.54	0.46	0.54	0.54	0.47	0.58	0.57	0.58	0.54	0.48	0.55	0.48	0.43
Long-term Debt	1.25	1.25	1.53	1.38	1.44	1.45	1.30	1.36	1.46	1.34	1.43	1.37	1.43	1.45	1.25	1.25	1.25
Total Non-current Liabilities*	1.47	1.47	1.78	1.66	1.72	1.74	1.60	1.66	1.77	1.64	1.72	1.67	1.73	1.77	1.59	1.59	1.60
Total Liabilities	2.08	2.09	2.28	2.23	2.26	2.20	2.13	2.21	2.24	2.22	2.29	2.24	2.28	2.25	2.14	2.07	2.03
Retained Earnings	1.00	1.00	1.01	1.12	1.10	1.08	1.09	1.05	1.02	0.99	0.95	0.91	0.88	0.87	0.83	0.80	0.79
Total Stockholder Equity	1.46	1.45	1.49	1.57	1.51	1.50	1.58	1.55	1.55	1.55	1.51	1.48	1.52	1.55	1.51	1.46	1.47

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	570.10	519.50	422.80	537.20	627.20	580.70	478.40	517.60	647.80	599.40	488.90	534.10	650.00	598.40	536.90	623.80	547.70	463.30	543.20	573.70
Cost of Revenue	327.60	302.60	261.80	328.60	358.70	324.50	286.80	304.80	360.70	341.30	291.20	303.70	370.30	356.70	318.10	383.20	317.60	273.40	298.40	303.40
Gross Profit	242.50	216.90	161.00	208.60	268.50	256.20	191.60	212.80	287.10	258.10	197.70	230.40	279.70	241.70	218.80	240.60	230.10	189.90	244.80	270.30
Research & Development	13.30	14.90	13.80	15.80	14.00	13.90	13.90	16.30	14.60	14.20	13.30	15.90	14.80	14.40	15.40	13.60	13.70	12.80	15.20	14.60
Selling, General & Admin	108.30	111.00	102.40	112.00	104.40	105.70	102.90	--	110.10	107.50	103.30	--	96.30	105.20	--	92.70	101.30	96.90	--	97.50
Total Operating Expenses	217.50	198.50	179.90	244.90	214.80	197.30	171.30	192.40	204.40	188.00	171.60	176.50	194.10	185.50	161.00	190.70	188.40	158.10	181.60	529.70
Operating Income	25.00	18.40	(18.90)	(36.30)	53.70	58.90	20.30	20.40	82.70	70.10	26.10	53.90	85.60	56.20	57.80	49.90	41.70	31.80	63.20	71.10
Interest Expense	16.70	17.90	19.30	14.80	19.40	20.20	18.80	17.50	18.80	20.40	19.80	18.70	19.20	20.70	18.10	18.00	18.00	17.30	16.80	16.40
Pretax Income	18.00	7.90	(36.90)	(53.20)	37.20	41.30	(1.70)	5.40	62.50	47.00	6.00	35.10	70.20	26.00	43.40	36.30	27.10	16.20	47.40	53.90
Tax Provision	5.70	3.90	(7.70)	(22.60)	8.10	12.30	0.40	(3.40)	13.50	11.00	1.20	3.80	17.70	7.00	9.70	5.80	3.90	5.00	3.30	13.10
Net Income	13.70	(10.60)	(65.70)	(30.60)	29.10	29.00	(2.10)	8.80	49.00	36.00	4.80	31.30	52.50	19.00	33.70	30.50	23.20	11.20	44.10	40.80
Basic EPS	0.30	(0.23)	(1.41)	(0.65)	0.62	0.60	(0.04)	0.17	0.99	0.72	0.10	0.62	1.03	0.37	0.64	0.58	0.43	0.21	0.81	0.75
Diluted EPS	0.29	(0.22)	(1.41)	(0.65)	0.62	0.60	(0.04)	0.18	0.98	0.72	0.09	0.60	1.01	0.37	0.64	0.57	0.43	0.20	0.80	0.74

Cash Flow Statement

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	118.70	54.30	(125.90)	74.10	114.80	45.10	(115.60)	73.70	101.20	129.00	(72.90)	47.80	168.30	(86.30)	29.60	112.30	39.10	(79.00)	73.10	174.70
Capital Expenditures	15.60	14.00	11.60	27.60	15.50	17.10	16.80	25.90	12.60	11.50	6.50	18.40	31.10	11.30	19.00	12.40	15.60	9.40	22.70	11.90
Free Cash Flow*	103.10	40.30	(137.50)	46.50	99.30	28.00	(132.40)	47.80	88.60	117.50	(79.40)	29.40	137.20	(97.60)	10.60	99.90	23.50	(88.40)	50.40	162.80
Investing Cash Flow	(14.10)	325.00	(9.90)	(27.60)	(12.30)	(17.30)	(15.70)	(25.50)	(17.20)	(13.70)	(6.00)	(18.90)	(31.60)	(11.20)	(17.80)	(11.90)	(13.00)	(312.70)	(22.60)	(12.50)
Financing Cash Flow	(7.30)	(300.80)	133.40	(19.10)	(83.40)	(37.40)	109.90	(40.10)	(79.90)	(129.20)	69.80	(14.20)	(132.30)	82.90	3.80	(99.70)	(77.20)	155.50	(5.50)	(7.80)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021	Q3 2016	Q2 2016	Q1 2016	Q4 2015	Q3 2014
Dividends Per Share	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.15	0.50	0.50	0.50	0.00	0.50